Parkinson's disease Archives

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Insider Brief PRESS RELEASE — Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has completed IND-enabling studies

18 Aug 2025 · 4 min read

Parkinson’s disease

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Trending today

Valon Raises $150M Series D at a $2.3B Valuation to Deploy ValonOS and AI Agents into Mortgage

Melius Secures $25M From CRV and General Catalyst to Build AI Agents for Ad Creative

Anthropic Expands Claude for Startups Program With Free Year of Claude Team and $1,000 in API Credits

AWS Launches Open-Source Physical AI Toolchain for Robotics Development

Deepslate Secures €7.7M Seed Funding to Build European Speech-to-Speech AI Models

Parkinson’s disease

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Trending today

Valon Raises $150M Series D at a $2.3B Valuation to Deploy ValonOS and AI Agents into Mortgage

Melius Secures $25M From CRV and General Catalyst to Build AI Agents for Ad Creative

Anthropic Expands Claude for Startups Program With Free Year of Claude Team and $1,000 in API Credits

AWS Launches Open-Source Physical AI Toolchain for Robotics Development

Deepslate Secures €7.7M Seed Funding to Build European Speech-to-Speech AI Models

The AI economy, every weekday morning